|
1) 平林真介, 真部 淳. 骨髄異形成症候群の中央診断: 445例の追跡調査. 日小血会誌. 2009; 23: 53-7
|
|
|
|
2) Kardos G, Baumann I, Passmore SJ, et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood. 2003; 102: 1997-2003
|
|
|
|
|
3) Strahm B, Locatelli F, Bader P, et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant. 2007; 40: 329-33
|
|
|
|
|
|
4) Hasegawa D, Manabe A, Yagasaki H, et al. Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group Trial (MDS99). Pediatr Blood Cancer. 2009; 53: 1011-5
|
|
|
|
|
|
5) Gohring G, Michalova K, Beverloo HB, et al. Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood. 2010; 116: 3766-9
|
|
|
|
|
|
6) Webb DK, Passmore SJ, Hann IM, et al. Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in trans-formation (RAEBt) in Great Britain 1990-1999. Br J Haematol. 2002; 117: 33-9
|
|
|
|
|
|
7) Strahm B, Nöllke P, Zecca M, et al. EWOG-MDS study group. Hematopoietic stem cell trans-plantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia. 2011; 25: 455-62
|
|
|
|
|
|
8) 真部 淳. 若年性骨髄単球性白血病の分子生物学. 臨床血液. 2010; 51: 526-31
|
|
|
|
|
9) Locatelli F, Nollke P, Zecca M, et al. Hemato-poietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood. 2005; 105: 410-9
|
|
|
|
|
|
10) Yabe M, Sako M, Yabe H, et al. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia. Pediatr Transplant. 2008; 12: 862-7
|
|
|
|
|